Europe Diagnostics Market By Product (Instruments, Reagents, Software & Services), By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others), By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Others), By End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Others), By Country, Competition, Forecast & Opportu

Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Europe Diagnostics Market By Product (Instruments, Reagents, Software & Services), By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others), By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Others), By End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Others), By Country, Competition, Forecast & Opportu

Europe diagnostics market is expected to grow at an impressive rate during the forecast period, 2024-2028. Growing incidences of various diseases along with extensive technological advancements in the country is likely to propel the growth of the market. Clinical diagnostics has open up new possibilities for early prevention and intervention by identifying the risk factors and early warning indications in a patient. As a result, it is projected that the entire market would continue to grow as the occurrences of chronic illnesses rises. Also, there is an increase in In-vitro diagnostic tests as well as increasing demand for genetic testing, which, in turn is surging the growth of the market.

Additionally, growing demand for Point-of-Care testing is a major factor for the market’s growth. This can be attributed to surging demand for self-testing diagnostics, and also the patient awareness regarding early diagnosis of the diseases. The growing popularity of personalized medicine among people for the treatments of several chronic diseases is likely to create lucrative opportunities for market growth over the next few years.

Growing Prevalence of Several Diseases and Disorders

According to the Global Cancer Observatory report, in 2020, 4,398,443 European people were suffering from cancer, out of which 1,955,231 people lost their lives due to cancer.

Increasing Aging Population

For instance


MIR Segment1

Recent Developments

  • In 2021, Rocheintroduced its Cobas Pulse System in select countries accepting CE markapproval in Europe. The item is a networked point-of-care solution from RocheDiagnostics' latest generation. The most recent release offers expert bloodglucose management.
  • In 2021, Hologic announcedthe European launch of Geniusâ„¢ Digital Diagnostics System for cervical cancerscreening. It is the next generation of cervical cancer screening that mergedeep learning-based artificial intelligence (AI) with advanced volumetricimaging technology to assist in identifying pre-cancerous lesions and cervicalcancer cells in women. It was developed to offer actionable insights, and to improveworkflow and lab efficiency, which primarily focus on eradicating cervicalcancer.

Download Free Sample Report

Market Segmentation

Europe diagnostics market is segmented into product, technology, application, end user, company and region. Based on product, the market is categorized into instruments, reagents, and software & services. Based on technology, the market is divided into

Market Players

Roche Diagnostics

Attribute

Details

Base Year

2022

Historic Data

2018 â€“ 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Product

·         Technology

·         Application

·         End User

·         Country

Country scope

France, Germany, United Kingdom, Italy, Spain, Finland, Greece, Portugal, Bulgaria, and Croatia.

Key companies profiled

Roche Diagnostics GmbH, Ortho Clinical Diagnostics., Abbott Laboratories, Inc., Hologic, Inc. (Gen-Probe), Qiagen N.V., Bio-Rad Laboratories, Inc., Quidel Corporation, Becton, Dickinson (BD) Company, Inc., bioMerieux, Inc., Siemens Healthcare GmbH.

Customization scope

10% free report customization with purchase. Addition or alteration to country, & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.